Details for Patent: 11,324,751
✉ Email this page to a colleague
Which drugs does patent 11,324,751 protect, and when does it expire?
Patent 11,324,751 protects INVEGA HAFYERA and is included in one NDA.
This patent has thirteen patent family members in thirteen countries.
Summary for Patent: 11,324,751
Title: | Dosing regimens associated with extended release paliperidone injectable formulations |
Abstract: | The present invention provides a method of treating patients with long acting injectable paliperidone palmitate formulations. |
Inventor(s): | Gopal; Srihari (Belle Mead, NJ), Venkatasubramanian; Raja (Newtown, PA), T'Jollyn; Huybrecht (Ghent, BE) |
Assignee: | Janssen Pharmaceutica NV (Beerse, BE) |
Application Number: | 17/314,281 |
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 11,324,751
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Janssen Pharms | INVEGA HAFYERA | paliperidone palmitate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 207946-005 | Aug 30, 2021 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | TREATMENT OF SCHIZOPHRENIA BY ADMINISTERING A DOSE UP TO TWO WEEKS BEFORE OR THREE WEEKS AFTER THE SCHEDULED SIX-MONTH DOSE | ⤷ Try a Trial | ||||
Janssen Pharms | INVEGA HAFYERA | paliperidone palmitate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 207946-006 | Aug 30, 2021 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | TREATMENT OF SCHIZOPHRENIA BY ADMINISTERING A DOSE UP TO TWO WEEKS BEFORE OR THREE WEEKS AFTER THE SCHEDULED SIX-MONTH DOSE | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,324,751
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2021387679 | ⤷ Try a Trial | |||
Canada | 3203448 | ⤷ Try a Trial | |||
China | 116507320 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |